Literature DB >> 12105393

Phosphatonins: a new class of phosphate-regulating proteins.

Susan C Schiavi1, Orson W Moe.   

Abstract

PURPOSE OF REVIEW: There is an intimate relationship between phosphate and calcium homeostasis throughout the animal kingdom. One traditional assumption is that all phosphate-regulating hormones are primarily calcium-regulating hormones. Although the notion of a circulating substance dedicated to phosphate homeostasis has existed for more than a decade, it is not until recently that these hormones have been identified. The molecular characterization of these substances will prove to be critical for understanding phosphate physiology and clinical disorders of phosphate metabolism. RECENT
FINDINGS: This review will focus primarily on the first two proteins recently shown to have phosphatonin properties. Using three human diseases as models and a combination of positional cloning and differential gene expression, fibroblast growth factor 23 and frizzled-related protein 4 were shown to be associated with one or more of these diseases. Although both of these substances have phosphaturic action, their biological effects are likely to extend beyond epithelial phosphate transport.
SUMMARY: The phosphatonins are a growing family of substances that may act on multiple organs in autocrine, paracrine, and endocrine modes to regulate phosphate metabolism. As this list expands, the need for a more rigid definition of the term phosphatonin becomes evident. The identification and characterization of these phosphate-regulatory compounds will provide a clearer understanding of how individual phosphatonins regulate phosphate in normal and disease physiology.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12105393     DOI: 10.1097/00041552-200207000-00009

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  12 in total

1.  Phosphatonin washout in Hyp mice proximal tubules: evidence for posttranscriptional regulation.

Authors:  Michel Baum; Orson W Moe; Jianning Zhang; Vangipuram Dwarakanath; Raymond Quigley
Journal:  Am J Physiol Renal Physiol       Date:  2004-09-28

Review 2.  Vitamin D and the kidney.

Authors:  Rajiv Kumar; Peter J Tebben; James R Thompson
Journal:  Arch Biochem Biophys       Date:  2012-03-15       Impact factor: 4.013

3.  Human recombinant endopeptidase PHEX has a strict S1' specificity for acidic residues and cleaves peptides derived from fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein.

Authors:  Marcelo Campos; Constance Couture; Izaura Y Hirata; Maria A Juliano; Thomas P Loisel; Philippe Crine; Luiz Juliano; Guy Boileau; Adriana K Carmona
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

4.  Taxonomy of rare genetic metabolic bone disorders.

Authors:  L Masi; D Agnusdei; J Bilezikian; D Chappard; R Chapurlat; L Cianferotti; J-P Devolgelaer; A El Maghraoui; S Ferrari; M K Javaid; J-M Kaufman; U A Liberman; G Lyritis; P Miller; N Napoli; E Roldan; S Papapoulos; N B Watts; M L Brandi
Journal:  Osteoporos Int       Date:  2015-06-13       Impact factor: 4.507

5.  FGF-23 and sFRP-4 in chronic kidney disease and post-renal transplantation.

Authors:  Sangeeta Pande; Cynthia S Ritter; Marcos Rothstein; Karen Wiesen; John Vassiliadis; Rajiv Kumar; Susan C Schiavi; Eduardo Slatapolsky; Alex J Brown
Journal:  Nephron Physiol       Date:  2006-05-10

6.  Biological activity of FGF-23 fragments.

Authors:  Theresa J Berndt; Theodore A Craig; Daniel J McCormick; Beate Lanske; Despina Sitara; Mohammed S Razzaque; Marlon Pragnell; Ann E Bowe; Stephen P O'Brien; Susan C Schiavi; Rajiv Kumar
Journal:  Pflugers Arch       Date:  2007-02-27       Impact factor: 3.657

7.  Renal phosphate wasting due to tumor-induced osteomalacia: a frequently delayed diagnosis.

Authors:  M Odette Gore; Brian J Welch; Weidong Geng; Wareef Kabbani; Naim M Maalouf; Joseph E Zerwekh; Orson W Moe; Khashayar Sakhaee
Journal:  Kidney Int       Date:  2008-07-30       Impact factor: 10.612

8.  Familial tumoral calcinosis: from characterization of a rare phenotype to the pathogenesis of ectopic calcification.

Authors:  Eli Sprecher
Journal:  J Invest Dermatol       Date:  2009-10-29       Impact factor: 8.551

9.  Correction of proximal tubule phosphate transport defect in Hyp mice in vivo and in vitro with indomethacin.

Authors:  Michel Baum; Samer Loleh; Neel Saini; Mouin Seikaly; Vangipuram Dwarakanath; Raymond Quigley
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-02       Impact factor: 11.205

10.  Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent.

Authors:  Theresa Berndt; Theodore A Craig; Ann E Bowe; John Vassiliadis; David Reczek; Richard Finnegan; Suzanne M Jan De Beur; Susan C Schiavi; Rajiv Kumar
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.